基质金属蛋白酶-9可能通过增加CD4+ T细胞上CD31的剪切影响非ST段抬高型急性冠脉综合征的适应性免疫
该研究探讨非ST段抬高型急性冠脉综合征(ACS)中CD31失调的机制,通过流式细胞术分析30例ACS、25例稳定型心绞痛(SA)和28例对照者CD4+ T细胞上CD31结构域1-5与6的比值,发现ACS组比值显著低于SA和对照组,且ACS组T细胞受体刺激后MMP-9产生更高,MMP-9抑制剂可增加CD31结构域1-5表达。结论提示MMP-9释放增强在ACS患者CD4+ T细胞功能性CD31结构域1-5的剪切和脱落中起关键作用,可能成为调节T细胞失调的治疗靶点。
要点
- ACS患者CD4+ T细胞CD31结构域1-5/6比值显著低于SA和对照组。
- ACS患者T细胞受体刺激后MMP-9产生显著高于SA患者。
- MMP-9抑制剂可增加ACS患者活化CD4+ T细胞CD31结构域1-5表达。
核心结论
- 增强的MMP-9释放可能在ACS患者CD4+ T细胞功能性CD31结构域1-5的剪切和脱落中起关键作用。
- 该机制可能成为调节ACS中T细胞失调的重要治疗靶点。
研究设计与样本
- 研究纳入30例ACS、25例稳定型心绞痛(SA)患者和28例对照(CTRL)。
- 采用流式细胞术分析CD4+ T细胞CD31结构域1-5与6比值,ELISA检测T细胞受体刺激后CD4+ T细胞上清MMP-9产生,并测试MMP-9抑制剂对CD31结构域1-5表达的影响。
主要发现
- CD31结构域1-5/6比值在ACS中显著低于SA(P=0.002)和CTRL(P=0.002)。
- 抗CD3/CD28刺激后,1-5/6结构域比值在ACS中显著低于SA(P=0.005)。
- T细胞受体刺激的CD4+ T细胞上清中MMP-9产生在ACS中高于SA(P<0.001)。
- ACS患者活化CD4+ T细胞CD31结构域1-5表达在特定MMP-9抑制剂处理后增加(P=0.042)。
临床怎么用
- MMP-9介导的CD31剪切可能作为评估ACS免疫失调的机制标志。
- MMP-9抑制剂可能成为调节ACS患者T细胞失调的潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: In patients with acute coronary syndrome (ACS), the higher activity of effector T-cells suggests that mechanisms involving adaptive immunity dysregulation might play a role in coronary instability. The shedding of the functional CD31 domain 1-5 leads to uncontrolled lymphocyte activation. In experimental models, matrix metalloproteinase-9 (MMP-9) has been implicated in endothelial CD31 cleavage. Interestingly, higher serum levels of MMP-9 have been observed in ACS. We aim to investigate the mechanisms underlying CD31 dysregulation in ACS. METHODS AND RESULTS: To assess CD31 cleavage on CD4+ T-cells, we analysed by flow cytometry CD4+ T-cells of 30 ACS, 25 stable angina (SA) patients, and 28 controls (CTRL) using two different CD31 antibodies that specifically recognize domain 1-5 or the non-functional membrane-proximal domain 6. The ratio between the domains was significantly lower in ACS than in SA and CTRL (P = 0.002 ACS vs. SA; P = 0.002 ACS vs. CTRL). After stimulation with anti-CD3/CD28, the 1-5/6 domain ratio was significantly lower in ACS than in SA (P = 0.005). ELISA of supernatants obtained from T-cell receptor-stimulated CD4+ T-cells showed higher production of MMP-9 in ACS than in SA (P < 0.001). CD31 domain 1-5 expression in activated CD4+ T-cells from ACS patients increased after treatment with a specific MMP-9 inhibitor (P = 0.042). CONCLUSION: Our study suggest that enhanced MMP-9 release plays a key role in determining the cleavage and shedding of the functional CD31 domain 1-5 in CD4+ T-cells of ACS patients. This mechanism might represent an important therapeutic target to modulate T-cell dysregulation in ACS.
引用
- Angelini G, Flego D, Vinci R, et al. Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells. Eur Heart J. 2018. PMID: 29211854. doi:10.1093/eurheartj/ehx684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。